De Paepe A - Search Results

1

Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.

Claes K, Poppe B, Machackova E, Coene I, Foretova L, De Paepe A, Messiaen L. Claes K, et al. Among authors: de paepe a. Genes Chromosomes Cancer. 2003 Jul;37(3):314-20. doi: 10.1002/gcc.10221. Genes Chromosomes Cancer. 2003. PMID: 12759930

2

Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.

Claes K, Vandesompele J, Poppe B, Dahan K, Coene I, De Paepe A, Messiaen L. Claes K, et al. Among authors: de paepe a. Oncogene. 2002 Jun 13;21(26):4171-5. doi: 10.1038/sj.onc.1205520. Oncogene. 2002. PMID: 12037674

3

Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms.

De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K. De Leeneer K, et al. Among authors: de paepe a. Clin Chem. 2008 Jun;54(6):982-9. doi: 10.1373/clinchem.2007.098764. Epub 2008 Apr 10. Clin Chem. 2008. PMID: 18403564 Free article.

4

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.

De Leeneer K, Coene I, Crombez B, Simkens J, Van den Broecke R, Bols A, Stragier B, Vanhoutte I, De Paepe A, Poppe B, Claes K. De Leeneer K, et al. Among authors: de paepe a. Breast Cancer Res Treat. 2012 Feb;132(1):87-95. doi: 10.1007/s10549-011-1544-9. Epub 2011 May 7. Breast Cancer Res Treat. 2012. PMID: 21553119

5

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL; CIMBA Consortium; Laitman Y, Kushnir A, Paluch-Shimon S, Berger R, Zidan J, Friedman E, Ehrencrona H, Stenmark-Askmalm M, Einbeigi Z, Loman N, Harbst K, Rantala J, Melin B, Huo D, Olopade OI, Seldon J, Ganz PA, Nussbaum RL, Chan SB, Odunsi K, Gayther SA, Domchek SM, Arun BK, Lu KH, Mitchell G, Karlan BY, Walsh C, Lester J, Godwin AK, Pathak H, Ross E, Daly MB, Whittemore AS, John EM, Miron A, Terry MB, Chung WK, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, Neuhausen SL, Ding YC, Ejlertsen B, Gerdes AM, Hansen Tv, Ramón y Cajal T, Osorio A, Benitez J, Godino J, Tejada MI, Duran M, Weitzel JN, Bobolis KA, Sand SR, Fontaine A, Savarese A, Pasini B, Peissel B, Bonanni B, Zaffaroni D, Vignolo-Lutati F, Scuvera G, Giannini G, Bernard L, Genuardi M, Radice P, Dolcetti R, Manoukian S, Pensotti V, Gismondi V, Yannoukakos D, Fostira F, Garber J, Torres D, Rashid MU, Hamann U, Peock S, Frost D, Platte R, Evans DG, Eeles R, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Hodgson S, Morrison PJ, Walker L, Porte… See abstract for full author list ➔ Rebbeck TR, et al. Among authors: de leeneer k, de paepe a, de la hoya m. JAMA. 2015 Apr 7;313(13):1347-61. doi: 10.1001/jama.2014.5985. JAMA. 2015. PMID: 25849179 Free PMC article.

6

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.

Claes K, Machackova E, De Vos M, Mortier G, De Paepe A, Messiaen L. Claes K, et al. Among authors: de vos m, de paepe a. Hum Mutat. 1999;13(3):256. doi: 10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M. Hum Mutat. 1999. PMID: 10090482

7

Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.

Claes K, Machackova E, De Vos M, Poppe B, De Paepe A, Messiaen L. Claes K, et al. Among authors: de vos m, de paepe a. Dis Markers. 1999 Oct;15(1-3):69-73. doi: 10.1155/1999/241046. Dis Markers. 1999. PMID: 10595255 Free PMC article.

8

Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.

Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, Berneman Z, De Bock R, De Paepe A, Speleman F. Van Limbergen H, et al. Among authors: de paepe a, de bock r. Genes Chromosomes Cancer. 2002 Jan;33(1):60-72. doi: 10.1002/gcc.1212. Genes Chromosomes Cancer. 2002. PMID: 11746988

9

EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.

Poppe B, Dastugue N, Vandesompele J, Cauwelier B, De Smet B, Yigit N, De Paepe A, Cervera J, Recher C, De Mas V, Hagemeijer A, Speleman F. Poppe B, et al. Among authors: de paepe a, de mas v, de smet b. Genes Chromosomes Cancer. 2006 Apr;45(4):349-56. doi: 10.1002/gcc.20295. Genes Chromosomes Cancer. 2006. PMID: 16342172

10

Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden.

De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K. De Leeneer K, et al. Among authors: de paepe a. J Mol Diagn. 2009 Sep;11(5):415-9. doi: 10.2353/jmoldx.2009.090032. Epub 2009 Jul 30. J Mol Diagn. 2009. PMID: 19644020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters